CSG's €275 Million Payment Fails to Halt 53% Stock Rout

The Czechoslovak Group has settled a €275 million related-party receivable in full during the first quarter of 2026, matching the timeline it laid out at the time of its initial public offering. The payment, which stemmed from the sale of non-core assets including CSG Mobility, Perazzi, and the healthcare division ahead of the IPO, was singled out as problematic by short seller Hunterbrook Capital earlier this month. But the clarification has done little to stem the bleeding.

Shares in the defence contractor slumped to €15.20 on Tradegate Friday, a near-19% single-day decline that dragged the stock roughly 53% below its January peak of €33.81. The rout has erased more than half of the company's market value since the start of the year, with the stock now trading around 35% below its 50-day moving average. Over the past 30 days alone, the equity has shed more than 36%.

The catalyst was a report from Hunterbrook Capital that questioned CSG's production capacity, business model, and disclosure practices. The stock lost roughly 13% in a single session after the report's release. CSG fired back, calling the analysis inaccurate and noting that Hunterbrook holds a disclosed short position in the stock. The company's rebuttal also addressed the €275 million receivable, confirming it had been fully repaid in the first quarter of 2026.

A Tale of Two Narratives

The operational picture tells a starkly different story from the share price. Revenue surged nearly 72% in fiscal 2025 to €6.7 billion, fuelled by organic growth and acquisitions. The order backlog swelled to a record €42 billion — though the secondary source puts that figure at over €15 billion, likely reflecting a narrower definition of firm orders. Management has guided for revenue of between €7.4 billion and €7.6 billion in 2026, with an operating margin of 24% to 25%.

Should investors sell immediately? Or is it worth buying CSG?

Production capacity is expanding too. The company expects in-house output to rise by roughly 20% this year, underpinned by a new manufacturing line in Slovakia capable of producing 70,000 additional units. Over the medium term, CSG is targeting annual capacity of 1.1 million rounds across facilities in Slovakia, Greece, Serbia, Spain, and India.

Despite the market turmoil, the group continues to build out its portfolio. Through its Excalibur International subsidiary, it secured contracts worth nearly $2.5 billion to supply air-defence systems in Southeast Asia — enough to keep production lines busy for the next four to five years. It also plans to acquire a 49% stake in Hirtenberger Defence Systems, an Austrian maker of mortar systems and ammunition. A framework agreement with Poland's PGZ for drone propulsion and rocket systems adds further heft.

The Silence Before the Storm

CSG has been in a mandatory quiet period since late April, preventing management from speaking publicly. That blackout lifts on May 20, when the company releases its first quarterly report as a listed entity. The results will for the first time disclose IPO-related costs incurred after year-end. Whether margins hold up despite those one-off charges will be a key focus for investors.

The Hunterbrook report has also revived scrutiny of earlier controversies, including a Slovak ammunition framework agreement that was presented as a reference project at the time of the IPO but has reportedly not been formally signed by any of the named countries, as well as a temporary suspension of a Spanish ammunition factory by NATO's procurement agency.

Analysts vs. the Market

Every single one of the nine analysts covering CSG rates the stock a buy. The average price target stands at €35.40 — more than double the current trading level. J.P. Morgan maintains an "Overweight" rating with a €40 target, citing strong margins and CSG's position as Europe's second-largest supplier of large-calibre ammunition. Morgan Stanley views the sell-off as sentiment-driven and lacking fundamental justification.

CSG at a turning point? This analysis reveals what investors need to know now.

Yet the market remains unconvinced. Beyond the short-seller pressure, speculation about a potential ceasefire in Ukraine is weighing on sentiment. Investors fear an end to hostilities could sap the defence spending boom that has fuelled CSG's growth.

The May 20 earnings release represents the next concrete opportunity for management to regain investor confidence. With the stock down more than half since its IPO and trading at a deep discount to analyst targets, the stakes could hardly be higher.

Ad

CSG Stock: New Analysis - 8 May

Fresh CSG information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.

Read our updated CSG analysis...

en | NL0015073TS8 | CSGS | boerse | 69291927 |